| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
PTHS
Pelthos Therapeutics
|
Jun 15, 2026 | BUY |
Strong Buy
+95.7% avg upside
8 analysts
|
$75.00
158.69% Upside
|
· |
|
TNXP
Tonix Pharma
|
Jun 15, 2026 | BUY |
Strong Buy
+133.2% avg upside
7 analysts
|
$65.00
441.29% Upside
|
· |
|
IXHL
Incannex Healthcare Limited Sponsored ADR
|
Jun 08, 2026 | BUY |
Strong Buy
+405.7% avg upside
1 analyst
|
$18.00
405.67% Upside
|
· |
|
NNVC
NanoViricides
|
May 26, 2026 | BUY |
Strong Buy
+301.8% avg upside
2 analysts
|
$6.00
328.59% Upside
|
· |
|
RVPH
Reviva Pharmaceuticals Holdings
|
May 21, 2026 | BUY |
Strong Buy
+7085.8% avg upside
9 analysts
|
$30.00
4818.07% Upside
|
+70.5% |
|
BCDA
BioCardia
|
May 18, 2026 | BUY |
Strong Buy
+1502.2% avg upside
5 analysts
|
$6.00
520.27% Upside
|
· |
|
VTVT
vTv Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
-6.9% avg upside
12 analysts
|
$55.00
56.90% Upside
|
-12.2% |
|
AQST
Aquestive Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+88.9% avg upside
10 analysts
|
$9.00
91.07% Upside
|
-9.0% |
|
TLPH
Talphera
|
May 14, 2026 | BUY |
Buy
+332.4% avg upside
15 analysts
|
$3.50
221.19% Upside
|
+0.0% |
|
SLS
SELLAS Life Sciences Group
|
May 13, 2026 | BUY |
Strong Buy
+768.2% avg upside
15 analysts
|
$10.00
24.28% Upside
|
+19.1% |
|
ACXP
Acurx Pharmaceuticals
|
May 13, 2026 | BUY |
Strong Buy
+4624.0% avg upside
4 analysts
|
$10.00
549.32% Upside
|
-12.1% |
|
ABEO
Abeona Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+195.8% avg upside
17 analysts
|
$20.00
246.60% Upside
|
-4.5% |
|
IMNN
Imunon
|
May 12, 2026 | BUY |
Strong Buy
+705.9% avg upside
11 analysts
|
$12.00
559.27% Upside
|
· |
|
VSTM
Verastem
|
May 08, 2026 | BUY |
Strong Buy
+260.2% avg upside
23 analysts
|
$18.00
336.97% Upside
|
-18.2% |
|
INTS
Intensity Therapeutics, Inc.
|
May 08, 2026 | BUY |
Strong Buy
+1441.3% avg upside
6 analysts
|
$30.00
665.36% Upside
|
-9.0% |
|
QNRX
Quoin Pharmaceuticals
|
May 08, 2026 | BUY |
Strong Buy
+661.3% avg upside
7 analysts
|
$35.00
652.72% Upside
|
-2.5% |
|
TOVX
Theriva Biologics
|
May 06, 2026 | BUY |
Strong Buy
+3100.9% avg upside
8 analysts
|
$4.00
1492.95% Upside
|
· |
|
SNGX
Soligenix
|
May 04, 2026 | BUY |
Buy
+726.0% avg upside
6 analysts
|
$1.50
275.44% Upside
|
· |
|
INMB
Inmune Bio
|
Apr 06, 2026 | BUY |
Buy
+753.2% avg upside
11 analysts
|
$7.00
382.80% Upside
|
+0.8% |
|
PDSB
PDS Biotechnology
|
Apr 02, 2026 | BUY |
Strong Buy
+1493.1% avg upside
11 analysts
|
$4.50
371.22% Upside
|
+51.2% |
|
BRNS
Barinthus Biotherapeutics
|
Mar 13, 2026 | BUY |
Strong Buy
+551.3% avg upside
5 analysts
|
$7.00
957.15% Upside
|
+11.0% |
|
IRD
Opus Genetics
|
Mar 10, 2026 | BUY |
Strong Buy
+154.5% avg upside
23 analysts
|
$9.00
121.09% Upside
|
-19.3% |
|
NRSN
Neurosense Therapeutics Ltd.
|
Feb 19, 2026 | BUY |
Strong Buy
+940.9% avg upside
5 analysts
|
$7.50
832.07% Upside
|
-14.4% |
|
HELP
Helus Pharma
|
Feb 17, 2026 | BUY |
Strong Buy
+861.2% avg upside
12 analysts
|
$30.00
542.41% Upside
|
· |
|
AKTX
Akari Therapeutics
|
Nov 19, 2025 | BUY |
Strong Buy
+957.3% avg upside
7 analysts
|
$280.00
2459.41% Upside
|
-26.7% |
|
GOVX
GeoVax Labs
|
Jun 17, 2025 | BUY |
Strong Buy
+5683.6% avg upside
5 analysts
|
$212.50
15758.26% Upside
|
-92.7% |
|
CNSP
CNS Pharmaceuticals
|
May 22, 2025 | BUY |
Strong Buy
+495.7% avg upside
5 analysts
|
$84.00
1687.14% Upside
|
-83.5% |
|
CANF
Can-Fite BioPharma
|
Apr 15, 2025 | BUY |
Strong Buy
+57.3% avg upside
8 analysts
|
$4.50
51.10% Upside
|
-87.4% |
|
TSE:XRTX
XORTX Therapeutics Inc
|
Feb 25, 2025 | BUY |
Strong Buy
+554.5% avg upside
1 analyst
|
$19.83
554.51% Upside
|
· |
|
SCLX
Scilex Holding Company
|
Jan 27, 2025 | BUY |
Strong Buy
+4351.2% avg upside
5 analysts
|
$490.00
6459.57% Upside
|
-41.4% |
|
GNPX
Genprex
|
Aug 13, 2024 | BUY |
Strong Buy
+1166.9% avg upside
5 analysts
|
$7.50
1166.84% Upside
|
-73.5% |
|
PXS
Pyxis Tankers
|
Jul 17, 2024 | BUY |
Strong Buy
+62.7% avg upside
4 analysts
|
$10.00
128.26% Upside
|
-44.8% |
|
IGC
IGC Pharma
|
Jul 17, 2024 | BUY |
Strong Buy
+1491.5% avg upside
2 analysts
|
$3.50
1173.15% Upside
|
-26.1% |
|
AWHL
Aspira Women's Health
|
May 02, 2024 | BUY |
Strong Buy
+1002.0% avg upside
6 analysts
|
$7.20
1369.47% Upside
|
-97.8% |
|
APVO
Aptevo Therapeutics
|
Mar 07, 2024 | BUY |
Strong Buy
+165.0% avg upside
4 analysts
|
$10.50
124.78% Upside
|
-99.0% |
|
SYBX
Synlogic
|
Dec 11, 2023 | BUY |
Buy
+3290.3% avg upside
11 analysts
|
$30.00
4125.42% Upside
|
-49.8% |
|
ACHV
Achieve Life Sciences
|
Nov 10, 2023 | BUY |
Strong Buy
+211.2% avg upside
12 analysts
|
$25.00
415.49% Upside
|
+6.4% |
|
AIM
AIM ImmunoTech
|
May 31, 2023 | BUY |
Buy
+1128.4% avg upside
5 analysts
|
$3.50
821.26% Upside
|
-21.7% |
|
ATHXQ
Athersys
|
Mar 06, 2023 | BUY |
Buy
+29964185.8% avg upside
8 analysts
|
$5.50
5499900.04% Upside
|
-99.5% |
|
HEPA
Hepion Pharmaceuticals
|
Jan 23, 2023 | BUY |
Strong Buy
+82042.8% avg upside
9 analysts
|
$80.00
133233.36% Upside
|
· |
|
ENVB
Enveric Biosciences
|
Nov 17, 2022 | BUY |
Strong Buy
+1150.0% avg upside
2 analysts
|
$7.00
446.97% Upside
|
-53.3% |
|
FRMM
Forum Markets
|
Oct 20, 2022 | BUY |
Strong Buy
+560.0% avg upside
4 analysts
|
$80.00
1484.16% Upside
|
· |
|
CELU
Celularity
|
Aug 25, 2022 | BUY |
Strong Buy
+1938.2% avg upside
6 analysts
|
$15.00
1893.94% Upside
|
-89.2% |
|
AMPE
Ampio Pharmaceuticals
|
Aug 05, 2022 | HOLD |
Buy
+9184.6% avg upside
4 analysts
|
— | -87.0% |
|
PLUR
Pluri
|
Jul 20, 2022 | BUY |
Strong Buy
+197.0% avg upside
8 analysts
|
$4.00
98.08% Upside
|
-25.7% |
|
NCEL
NewcelX
|
Jul 05, 2022 | BUY |
Buy
+262.5% avg upside
4 analysts
|
— | · |
|
SCPX
Scorpius Holdings
|
Mar 15, 2022 | BUY |
Strong Buy
+1664672.8% avg upside
11 analysts
|
$15.50
1408990.93% Upside
|
· |
|
ORMP
Oramed Pharm
|
Nov 09, 2021 | BUY |
Strong Buy
+394.8% avg upside
7 analysts
|
$40.00
930.86% Upside
|
-78.7% |
|
AIXC
AIxCrypto Holdings
|
Sep 03, 2021 | BUY |
Strong Buy
+653.4% avg upside
7 analysts
|
$6.50
345.26% Upside
|
· |
|
ONCSQ
OncoSec Medical
|
Apr 15, 2021 | BUY |
Strong Buy
+4699999900.0% avg upside
9 analysts
|
$11.00
1099999899.93% Upside
|
· |
|
SRNE
Sorrento Therapeutics
|
Jan 21, 2021 | BUY |
Strong Buy
+2272627.3% avg upside
7 analysts
|
$35.00
3181718.28% Upside
|
-61.8% |
|
PYPD
PolyPid
|
Aug 10, 2020 | BUY |
Strong Buy
+248.1% avg upside
7 analysts
|
$27.00
469.54% Upside
|
-36.0% |
|
APM
Aptorum Group
|
Jul 13, 2020 | BUY |
Strong Buy
+1222.0% avg upside
1 analyst
|
$11.00
1221.95% Upside
|
-8.9% |
|
CYTOF
Altamira Therapeutics
|
Oct 08, 2018 | BUY |
Strong Buy
+16248.7% avg upside
4 analysts
|
$50.00
38825.70% Upside
|
· |
|
TVRD
Tvardi Therapeutics
|
Jun 30, 2017 | BUY |
Buy
+585.4% avg upside
23 analysts
|
$30.00
1040.78% Upside
|
+24.4% |
|
MTVA
MetaVia
|
Sep 06, 2016 | BUY |
Strong Buy
+1769.3% avg upside
13 analysts
|
$20.00
1150.06% Upside
|
-24.4% |
|
RMTI
Rockwell Med
|
Jan 27, 2015 | BUY |
Buy
+1445.2% avg upside
11 analysts
|
$25.00
3806.34% Upside
|
-36.9% |
|
EBS
Emergent Biosolutions
|
May 15, 2014 | BUY |
Buy
+216.6% avg upside
9 analysts
|
$35.00
337.45% Upside
|
+47.0% |
|
AMRX
Amneal Pharmaceuticals
|
Nov 13, 2013 | BUY |
Strong Buy
+5.6% avg upside
18 analysts
|
$30.00
85.13% Upside
|
· |
|
IRWD
Ironwood Pharma
|
Jul 24, 2013 | BUY |
Hold
+235.6% avg upside
23 analysts
|
— | +33.5% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.